Bladder cancer remains a leading cause of cancer-related mortality in the United States, with most cases classified as conventional urothelial carcinoma. However, a substantial subset of patients presents with aggressive variant histologies, including sarcomatoid, plasmacytoid, and micropapillary subtypes. These varian...
Gabriella U. Nanjo, Zi-Rui Fu, S. Smani et al.· Urologic oncology· 0 citations
ML models using preoperative variables achieved moderate discrimination for predicting adverse pathological features in UTUC and external validation and prospective assessment of clinical utility are necessary before informing preoperative patient selection.
Philipp Korn, Maximilian Pallauf, S. Lokeshwar et al.· Urologic oncology· 0 citations
Overall, incontinence prevention and treatment after RARP is becoming increasingly individualized with many options available for clinicians to offer to patients and continued innovation and discovery in functional recovery after RP are imperative.
Agustín Pérez Londoño, Aditi Yellu, Riley Hanes et al.· Current Urology Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.